These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 39096122)

  • 1. Potentially functional variants of ERRFI1 in hypoxia-related genes predict survival of non-small cell lung cancer patients.
    Wang H; Liu H; Lu G; Tang X; Luo S; Du M; Christiani DC; Wei Q
    Cancer Med; 2024 Aug; 13(15):e70073. PubMed ID: 39096122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentially functional genetic variants in the TNF/TNFR signaling pathway genes predict survival of patients with non-small cell lung cancer in the PLCO cancer screening trial.
    Guo Y; Feng Y; Liu H; Luo S; Clarke JW; Moorman PG; Su L; Shen S; Christiani DC; Wei Q
    Mol Carcinog; 2019 Jul; 58(7):1094-1104. PubMed ID: 30989732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentially functional genetic variants in the complement-related immunity gene-set are associated with non-small cell lung cancer survival.
    Qian D; Liu H; Wang X; Ge J; Luo S; Patz EF; Moorman PG; Su L; Shen S; Christiani DC; Wei Q
    Int J Cancer; 2019 Apr; 144(8):1867-1876. PubMed ID: 30259978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentially functional variants of ERAP1, PSMF1 and NCF2 in the MHC-I-related pathway predict non-small cell lung cancer survival.
    Yang S; Tang D; Zhao YC; Liu H; Luo S; Stinchcombe TE; Glass C; Su L; Shen S; Christiani DC; Wang Q; Wei Q
    Cancer Immunol Immunother; 2021 Oct; 70(10):2819-2833. PubMed ID: 33651148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel genetic variants in KIF16B and NEDD4L in the endosome-related genes are associated with nonsmall cell lung cancer survival.
    Yang S; Tang D; Zhao YC; Liu H; Luo S; Stinchcombe TE; Glass C; Su L; Shen S; Christiani DC; Wang Q; Wei Q
    Int J Cancer; 2020 Jul; 147(2):392-403. PubMed ID: 31618441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variants of CHEK1, PRIM2 and CDK6 in the mitotic phase-related pathway are associated with nonsmall cell lung cancer survival.
    Mu R; Liu H; Luo S; Patz EF; Glass C; Su L; Du M; Christiani DC; Jin L; Wei Q
    Int J Cancer; 2021 Sep; 149(6):1302-1312. PubMed ID: 34058013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variants in DDO and PEX5L in peroxisome-related pathways predict non-small cell lung cancer survival.
    Chen AS; Liu H; Wu Y; Luo S; Patz EF; Glass C; Su L; Du M; Christiani DC; Wei Q
    Mol Carcinog; 2022 Jul; 61(7):619-628. PubMed ID: 35502931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentially functional genetic variants in PLIN2, SULT2A1 and UGT1A9 genes of the ketone pathway and survival of nonsmall cell lung cancer.
    Tang D; Zhao YC; Liu H; Luo S; Clarke JM; Glass C; Su L; Shen S; Christiani DC; Gao W; Wei Q
    Int J Cancer; 2020 Sep; 147(6):1559-1570. PubMed ID: 32072637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentially functional variants of HBEGF and ITPR3 in GnRH signaling pathway genes predict survival of non-small cell lung cancer patients.
    Wu Y; Liu Z; Tang D; Liu H; Luo S; Stinchcombe TE; Glass C; Su L; Lin L; Christiani DC; Wang Q; Wei Q
    Transl Res; 2021 Jul; 233():92-103. PubMed ID: 33400994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variants in genes of tricarboxylic acid cycle key enzymes are associated with prognosis of patients with non-small cell lung cancer.
    Guo X; Li D; Wu Y; Chen Y; Zhou X; Wang X; Huang X; Li X; Yang H; Xing J
    Lung Cancer; 2015 Feb; 87(2):162-8. PubMed ID: 25576295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variants of genes in the Notch signaling pathway predict overall survival of non-small cell lung cancer patients in the PLCO study.
    Xu Y; Wang Y; Liu H; Kang X; Li W; Wei Q
    Oncotarget; 2016 Sep; 7(38):61716-61727. PubMed ID: 27557513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variant of IRAK2 in the toll-like receptor signaling pathway and survival of non-small cell lung cancer.
    Xu Y; Liu H; Liu S; Wang Y; Xie J; Stinchcombe TE; Su L; Zhang R; Christiani DC; Li W; Wei Q
    Int J Cancer; 2018 Nov; 143(10):2400-2408. PubMed ID: 29978465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants in ABCG1 are associated with survival of nonsmall-cell lung cancer patients.
    Wang Y; Liu H; Ready NE; Su L; Wei Y; Christiani DC; Wei Q
    Int J Cancer; 2016 Jun; 138(11):2592-601. PubMed ID: 26757251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Polymorphisms in Activating Transcription Factor 3 Binding Site and the Prognosis of Early-Stage Non-Small Cell Lung Cancer.
    Kang HG; Park JE; Lee SY; Choi JE; Do SK; Hong MJ; Lee JH; Jeong JY; Do YW; Lee EB; Shin KM; Lee WK; Choi SH; Lee YH; Seo HW; Yoo SS; Lee J; Cha SI; Kim CH; Cho S; Jheon S; Park JY
    Oncology; 2021; 99(5):336-344. PubMed ID: 33626541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel genetic variants in HDAC2 and PPARGC1A of the CREB-binding protein pathway predict survival of non-small-cell lung cancer.
    Tang D; Zhao YC; Qian D; Liu H; Luo S; Patz EF; Moorman PG; Su L; Shen S; Christiani DC; Glass C; Gao W; Wei Q
    Mol Carcinog; 2020 Jan; 59(1):104-115. PubMed ID: 31713888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The associations of TERT-CLPTM1L variants and TERT mRNA expression with the prognosis of early stage non-small cell lung cancer.
    Chen Z; Wang J; Bai Y; Wang S; Yin X; Xiang J; Li X; He M; Zhang X; Wu T; Xu P; Guo H
    Cancer Gene Ther; 2017 Jan; 24(1):20-27. PubMed ID: 27982019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy.
    Wu X; Ye Y; Rosell R; Amos CI; Stewart DJ; Hildebrandt MA; Roth JA; Minna JD; Gu J; Lin J; Buch SC; Nukui T; Ramirez Serrano JL; Taron M; Cassidy A; Lu C; Chang JY; Lippman SM; Hong WK; Spitz MR; Romkes M; Yang P
    J Natl Cancer Inst; 2011 May; 103(10):817-25. PubMed ID: 21483023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variants in RUNX3, AMD1 and MSRA in the methionine metabolic pathway and survival in nonsmall cell lung cancer patients.
    Chen K; Liu H; Liu Z; Luo S; Patz EF; Moorman PG; Su L; Shen S; Christiani DC; Wei Q
    Int J Cancer; 2019 Aug; 145(3):621-631. PubMed ID: 30650190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variants in the human leukocyte antigen region and survival of Chinese patients with non-small cell lung carcinoma.
    Cheng L; Liu Q; Wang M; Gu Y; Wang J; Wei Q; Zhang R
    Carcinogenesis; 2020 Sep; 41(9):1203-1212. PubMed ID: 32614429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia pathway genetic variants predict survival of non-small-cell lung cancer patients receiving platinum-based chemotherapy.
    Li R; Gu J; Heymach JV; Shu X; Zhao L; Han B; Ye Y; Roth J; Wu X
    Carcinogenesis; 2017 Apr; 38(4):419-424. PubMed ID: 28186269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.